CIK 0001439222
- Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- 4 Open-market sale Chief Executive Officer sold 23,572 shares at an average $81.09 ($1,911,494)
- 4 Open-market sale Principal Accounting Officer sold 2,150 shares at $75.00 ($161,250)
- 4 Open-market sale Chief Executive Officer sold 20 shares at $80.01 ($1,600)
- 4/A Derivatives Options or other derivatives
- 4 Open-market sale Chief Commercial Officer sold 25,000 shares at $74.83 ($1,870,750)
- 4 Open-market sale Chief Executive Officer sold 46,408 shares at $80.01 ($3,713,104)
- 4/A Derivatives Options or other derivatives
- 4 Open-market buy 10% owner bought 851,154 shares at $67.00 ($57,027,318)
- 4 Open-market sale Chief Executive Officer sold 53,000 shares at an average $73.16 ($3,877,218)
- 4 Open-market sale Chief Scientific Officer sold 3,000 shares at $65.00 ($195,000)
- 4 Open-market sale Director sold 3,838 shares at an average $59.37 ($227,857)
- 4 Exercise or conversion Chief Scientific Officer acquired 46,795 shares (option exercise)
- 4 Open-market sale Chief Executive Officer sold 6,000 shares at an average $61.55 ($369,288)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Scientific Officer sold 2,146 shares at an average $60.79 ($130,459)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 4,000 shares at an average $60.88 ($243,540)
- 4 Open-market sale Chief Scientific Officer sold 2,146 shares at an average $62.69 ($134,522)
- 4 Open-market sale Chief Executive Officer sold 6,000 shares at an average $63.85 ($383,105)
- 4 Open-market sale Director sold 4,000 shares at an average $71.10 ($284,380)
Page 23 of 38 · 758 filings